{
  "cik": 1759425,
  "cik_padded": "0001759425",
  "entityName": "Mirum Pharmaceuticals, Inc.",
  "fiscal_years": [
    {
      "accn": "0001759425-26-000013",
      "filed": "2026-02-25",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 954000.0,
        "cash": 296683000.0,
        "eps_diluted": -0.47,
        "free_cash_flow": 54873000.0,
        "net_income": -23363000.0,
        "operating_cash_flow": 55827000.0,
        "operating_income": -22136000.0,
        "revenue": 521312000.0,
        "stockholders_equity": 314690000.0,
        "total_assets": 842813000.0,
        "total_liabilities": 528123000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 1.6782325463154215,
        "net_margin": -0.04481577251243018,
        "operating_margin": -0.042462095635627035,
        "revenue_growth_yoy": 0.5474341620954145,
        "roa_avg2y": -0.030871444739479652,
        "roa_period_end": -0.027720265349490337,
        "roe_avg2y": -0.08647678270686432,
        "roe_period_end": -0.07424131685150466
      }
    },
    {
      "accn": "0001759425-26-000013",
      "filed": "2026-02-25",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 993000.0,
        "cash": 222503000.0,
        "eps_diluted": -1.85,
        "free_cash_flow": 9332000.0,
        "net_income": -87942000.0,
        "operating_cash_flow": 10325000.0,
        "operating_income": -87606000.0,
        "revenue": 336888000.0,
        "stockholders_equity": 225640000.0,
        "total_assets": 670754000.0,
        "total_liabilities": 445114000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 1.9726732848785675,
        "net_margin": -0.2610422454940514,
        "operating_margin": -0.26004488138491133,
        "revenue_growth_yoy": 0.807591187612006,
        "roa_avg2y": -0.13351095929405066,
        "roa_period_end": -0.1311091696806877,
        "roe_avg2y": -0.3708207712255698,
        "roe_period_end": -0.3897447261123914
      }
    },
    {
      "accn": "0001759425-26-000013",
      "filed": "2026-02-25",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 109000.0,
        "cash": 286326000.0,
        "eps_diluted": -4.0,
        "free_cash_flow": -71053000.0,
        "net_income": -163415000.0,
        "operating_cash_flow": -70944000.0,
        "operating_income": -109154000.0,
        "revenue": 186374000.0,
        "stockholders_equity": 248670000.0,
        "total_assets": 646621000.0,
        "total_liabilities": 397951000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 1.6003176901113927,
        "net_margin": -0.8768122162962645,
        "operating_margin": -0.5856718211767736,
        "revenue_growth_yoy": 1.4184941994757467,
        "roa_avg2y": -0.3269846637459518,
        "roa_period_end": -0.25272145507182725,
        "roe_avg2y": -0.8365091999887384,
        "roe_period_end": -0.6571560702939638
      }
    },
    {
      "accn": "0001759425-26-000013",
      "filed": "2026-02-25",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 278000.0,
        "cash": 28003000.0,
        "eps_diluted": -4.02,
        "free_cash_flow": -120414000.0,
        "net_income": -135665000.0,
        "operating_cash_flow": -120136000.0,
        "operating_income": -131220000.0,
        "revenue": 77062000.0,
        "stockholders_equity": 142037000.0,
        "total_assets": 352906000.0,
        "total_liabilities": 210869000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 1.484606123756486,
        "revenue_growth_yoy": 3.0266485526178286,
        "roa_avg2y": -0.41900558560868,
        "roa_period_end": -0.3844224807739171,
        "roe_avg2y": -1.0346273961006525,
        "roe_period_end": -0.9551384498405345
      }
    },
    {
      "accn": "0001759425-25-000014",
      "filed": "2025-02-26",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 24000.0,
        "cash": 31340000.0,
        "eps_diluted": -2.77,
        "free_cash_flow": -132782000.0,
        "net_income": -83988000.0,
        "operating_cash_flow": -132758000.0,
        "operating_income": -173413000.0,
        "revenue": 19138000.0,
        "stockholders_equity": 120212000.0,
        "total_assets": 294651000.0,
        "total_liabilities": 174439000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 1.4510947326390045,
        "roa_avg2y": -0.31367188594157025,
        "roa_period_end": -0.28504230428540883,
        "roe_avg2y": -0.5746560978697055,
        "roe_period_end": -0.6986656906132499
      }
    },
    {
      "accn": "0000950170-24-032289",
      "filed": "2024-03-15",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 225000.0,
        "cash": 142086000.0,
        "free_cash_flow": -89300000.0,
        "net_income": -103270000.0,
        "operating_cash_flow": -89075000.0,
        "operating_income": -104296000.0,
        "stockholders_equity": 172095000.0,
        "total_assets": 240864000.0,
        "total_liabilities": 68769000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.3995990586594613,
        "roa_avg2y": -0.5329019340722851,
        "roa_period_end": -0.4287481732429919,
        "roe_avg2y": -0.6829032812685984,
        "roe_period_end": -0.6000755396728551
      }
    },
    {
      "accn": "0001564590-21-011756",
      "filed": "2022-03-09",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 281000.0,
        "cash": 11970000.0,
        "free_cash_flow": -39643000.0,
        "net_income": -52553000.0,
        "operating_cash_flow": -39362000.0,
        "operating_income": -54743000.0,
        "stockholders_equity": 130349000.0,
        "total_assets": 146712000.0,
        "total_liabilities": 16363000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.1255322250266592,
        "roa_avg2y": -0.5290029040651879,
        "roa_period_end": -0.3582051911227439,
        "roe_avg2y": -0.9298453590006723,
        "roe_period_end": -0.4031714857804816
      }
    },
    {
      "accn": "0001564590-21-011756",
      "filed": "2021-03-09",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 51963000.0,
        "stockholders_equity": -17313000.0,
        "total_assets": 51975000.0,
        "total_liabilities": 2449000.0
      },
      "period_end": "2018-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001759425-26-000013",
    "filed": "2026-02-25",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001759425.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001759425.json"
  },
  "ticker": "MIRM"
}